Zobrazeno 1 - 10
of 186
pro vyhledávání: '"N. Horschowski"'
Autor:
Colette Charpin, Stéphane Garcia, Pascal Bonnier, N Horschowski, Claude Allasia, F Martini, Marie-Noëlle Lavaut, Lucile Andrac
Publikováno v:
Journal of Clinical Oncology. 16:2025-2031
PURPOSE bcl-2 protein is detectable in human cancers and may be involved in the response to antineoplastic drugs or endocrine therapy in breast carcinomas. In a previous study, we had developed optimal technical conditions for bcl-2 immunodetection.
Autor:
Stéphane Garcia, D Bergeret, Colette Charpin, Lavaut Mn, N Horschowski, R Choux, Lucile Andrac
Publikováno v:
British Journal of Cancer
VLA2 is thought to be involved in the metastatic process in malignant tumours, in particular in carcinomatous cell adhesion to vessel basement membrane. VLA2 expression was immunohistochemically investigated in 204 breast carcinomas. Frozen tissue se
Autor:
C. Guillemain, Marianne Courcoul, Corinne Brunet, C. Dhiver, B. Spire, F. George, J. Sampol, M. Conciatori, N. Horschowski
Publikováno v:
ResearcherID
A small number of patients seropositive for the human immunodeficiency virus (HIV) have been reported as developing acute non-lymphoblastic leukemia (ANLL). In the cases previously published, the authors never reported a study of the link joining HIV
Publikováno v:
Biochemical and Biophysical Research Communications. 218:210-216
We have recently described a monoclonal antibody, S-Endo 1, recognizing a molecule constitutively expressed in all types of human endothelial cells. We showed that this protein around 118 kDa and located at the endothelial cell-cell junction presente
Autor:
Claude Allasia, Piana L, Lavaut Mn, N. Horschowski, Lucile Andrac, F. Duffaud, Devictor B, P. Vielh, Colette Charpin
Publikováno v:
JNCI Journal of the National Cancer Institute. 86:1539-1545
BACKGROUND Chemotherapy failure that is due to cellular drug resistance remains a major problem in most cancer patients. One type of drug resistance that has been characterized is the multidrug resistance phenomenon, which demonstrates a reduced abil
Autor:
B, Granel, R, Bouabdallah, J, Serratrice, L, Swiader, V, Veit, N, Horschowski, L, Xerri, P, Disdier, P -J., Weiller
Publikováno v:
European journal of internal medicine. 12(1)
We report a retrospective study of 11 patients suffering from T-cell non-Hodgkin lymphomas preceded by immunological disorders including two chronic granulomatous diseases, one midline granuloma, four autoimmune hematologic disorders, one hypereosino
Autor:
A, Donnet, N, Horschowski, H, Dufour, D, Figarella-Branger, P A, Bryon, F, Berger, J R, Harle, F, Grisoli
Publikováno v:
Journal of neuro-oncology. 47(2)
Intracranial pseudolymphoma is a rare tumor of the central nervous system. A 35-year-old woman presented with a frontal subcutaneous tumor. Magnetic resonance imaging revealed a left frontal meningeal tumor involving subcutaneous tissue without bone
Publikováno v:
European journal of dermatology : EJD. 8(7)
We report a new observation of granulomatous mycosis fungoides. The diagnosis was able to be made only after performing multiple biopsies during the course of the disease. Initial evolution was rapidly favourable with electrontherapy. A granulomatous
Publikováno v:
Human pathology. 29(9)
Expression of vascular cell adhesion molecules (VCAM) in tumors is associated with endothelial cell activation and may facilitate adherence of carcinomatous cells to the vessel wall, promoting bloodborne metastases. Expression of VCAM was investigate
Autor:
D Bergeret, Colette Charpin, N Horschowski, F Martini, Lavaut Mn, R Choux, Stéphane Garcia, Lucile Andrac
Publikováno v:
International Journal of Oncology.
ELAM is an E-Selectin adhesion molecule involved in the inflammatory process but it is also thought to potentially participate in the development of blood borne metastases, by facilitating tumour cell adhesion to vessels wall. ELAM expression in tumo